Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer. [electronic resource]
Producer: 20100309Description: 875-82 p. digitalISSN:- 1538-7445
- Abdominal Pain -- etiology
- Adult
- Aged
- Aged, 80 and over
- Animals
- Carcinoembryonic Antigen -- genetics
- Chlorocebus aethiops
- Fatigue -- etiology
- Female
- Fever -- etiology
- Humans
- Injections, Intraperitoneal
- Measles virus -- genetics
- Middle Aged
- Neoplasm Recurrence, Local
- Oncolytic Virotherapy -- adverse effects
- Oncolytic Viruses -- genetics
- Ovarian Neoplasms -- pathology
- Recombinant Fusion Proteins -- administration & dosage
- Treatment Outcome
- Vero Cells
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.